Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Acta Pharmacol Sin ; 2024 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-38914678

RESUMEN

Thymic egress is a crucial process for thymocyte maturation, strictly regulated by sphingosine-1-phosphate lyase (S1PL). Recently, cystathionine γ-lyase (CSE), one of the enzymes producing hydrogen sulfide (H2S), has emerged as a vital immune process regulator. However, the molecular connection between CSE, H2S and thymic egress remains largely unexplored. In this study, we investigated the regulatory function of CSE in the thymic egress of immune cells. We showed that genetic knockout of CSE or pharmacological inhibition by CSE enzyme inhibitor NSC4056 or D,L-propargylglycine (PAG) significantly enhanced the migration of mature lymphocytes and monocytes from the thymus to the peripheral blood, and this redistribution effect could be reversed by treatment with NaHS, an exogenous donor of H2S. In addition, the CSE-generated H2S significantly increased the levels of S1P in the peripheral blood, thymus and spleen of mice, suppressed the production of proinflammatory cytokines and rescued pathogen-induced sepsis in cells and in vivo. Notably, H2S or polysulfide inhibited S1PL activity in cells and an in vitro purified enzyme assay. We found that this inhibition relied on a newly identified C203XC205 redox motif adjacent to the enzyme's active site, shedding light on the biochemical mechanism of S1PL regulation. In conclusion, this study uncovers a new function and mechanism for CSE-derived H2S in thymic egress and provides a potential drug target for treating S1P-related immune diseases.

2.
Opt Express ; 31(17): 27962-27972, 2023 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-37710861

RESUMEN

We present a high-performance broadband (450-1550 nm) black phosphorus photodetector based on a thin-film lithium niobate waveguide. The waveguides are fabricated by the proton exchange method with flat surfaces, which reduces the stress and deformation of two-dimensional materials. At a wavelength of 1550 nm, the photodetector simultaneously achieves a high responsivity and wide bandwidth, with a responsivity as high as 147 A/W (at an optical power of 17 nW), a 3-dB bandwidth of 0.86 GHz, and a detectivity of 3.04 × 1013 Jones. Our photodetector exhibits one of the highest responsivity values among 2D material-integrated waveguide photodetectors.

3.
Chembiochem ; 23(3): e202100539, 2022 02 04.
Artículo en Inglés | MEDLINE | ID: mdl-34850523

RESUMEN

The discovery of a bioactive inhibitor tool for human polypeptide N-acetylgalactosaminyl transferases (GalNAc-Ts), the initiating enzyme for mucin-type O-glycosylation, remains challenging. In the present study, we identified an array of quinic acid derivatives, including four new glycerates (1-4) from Tussilago farfara, a traditional Chinese medicinal plant, as active inhibitors of GalNAc-T2 using a combined screening approach with a cell-based T2-specific sensor and purified enzyme assay. These inhibitors dose-dependently inhibited human GalNAc-T2 but did not affect O-linked N-acetylglucosamine transferase (OGT), the other type of glycosyltransferase. Importantly, they are not cytotoxic and retain inhibitory activity in cells lacking elongated O-glycans, which are eliminated by the CRISPR/Cas9 gene editing tool. A structure-activity relationship study unveiled a novel quinic acid-caffeic acid conjugate pharmacophore that directs inhibition. Overall, these new natural product inhibitors could serve as a basis for developing an inhibitor tool for GalNAc-T2.


Asunto(s)
Inhibidores Enzimáticos/farmacología , N-Acetilgalactosaminiltransferasas/antagonistas & inhibidores , Ácido Quínico/farmacología , Tussilago/química , Células Cultivadas , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Flores/química , Flores/metabolismo , Glicosilación , Células HEK293 , Humanos , Conformación Molecular , N-Acetilgalactosaminiltransferasas/aislamiento & purificación , N-Acetilgalactosaminiltransferasas/metabolismo , Ácido Quínico/química , Ácido Quínico/metabolismo , Relación Estructura-Actividad , Tussilago/metabolismo , Polipéptido N-Acetilgalactosaminiltransferasa
4.
Am J Physiol Gastrointest Liver Physiol ; 321(2): G149-G156, 2021 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-34160291

RESUMEN

Bile acid reflux in the esophagus plays a role in the pathogenesis of certain esophageal disorders, where it can induce esophageal pain and heartburn. The present study aimed to determine whether bile acid, deoxycholic acid (DCA), directly activates and sensitizes esophageal vagal nociceptive afferent C-fiber subtypes. DCA-elicited effects on vagal nodose and jugular neurons were studied by calcium imaging. Its effects on esophageal-labeled nodose and jugular neurons were then determined by patch-clamp recording. At nodose and jugular C-fiber nerve endings in the esophagus, DCA-evoked action potentials (APs) were compared by extracellular single-unit recordings in ex vivo esophageal-vagal preparations. DCA application induced calcium influxes in nodose and jugular neurons and elicited inward currents in esophageal-labeled nodose and jugular neurons. In the presence of DCA, the current densities elicited by capsaicin were enhanced in those labeled neurons. Consistently, DCA perfusion at nerve terminals in the esophagus evoked APs in about 50% of esophageal nodose and jugular C-fibers. In DCA-sensitive C-fibers, DCA perfusion also sensitized the fibers such that the subsequent response to capsaicin was amplified. Collectively, these results provide new evidence that DCA directly activates and sensitizes nociceptive nodose and jugular C-fibers in the esophagus. Such activation and sensitization effects may contribute to bile acid-induced esophageal nociceptive symptoms that are refractory to proton-pump inhibitor therapy.NEW & NOTEWORTHY Bile acid reflux in the esophagus can induce pain and heartburn in certain esophageal disorders, but the underlying neuronal mechanism is still unclear. The present study demonstrated that bile acid, deoxycholic acid (DCA), directly activates esophageal vagal afferent nodose and jugular nociceptive C-fibers and sensitizes their response to capsaicin. Such effects may contribute to bile acid-induced esophageal nociceptive symptoms that refractory to proton-pump inhibitors (PPIs) therapy.


Asunto(s)
Potenciales de Acción , Colagogos y Coleréticos/farmacología , Ácido Desoxicólico/farmacología , Esófago/fisiología , Nociceptores/fisiología , Animales , Señalización del Calcio , Células Cultivadas , Esófago/inervación , Cobayas , Fibras Nerviosas Amielínicas/efectos de los fármacos , Fibras Nerviosas Amielínicas/fisiología , Nociceptores/efectos de los fármacos , Nociceptores/metabolismo , Nervio Vago/efectos de los fármacos , Nervio Vago/fisiología
5.
Bioorg Chem ; 116: 105400, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34627118

RESUMEN

Fifteen previously undescribed nor-clerodane diterpenoid glucosides tinosinesides C-Q (1-15), along with four known analogues (16-19), were isolated from the stems of Tinospora sinensis. The structures of the new compounds were elucidated by spectroscopic means, and their absolute configurations were established on the basis of time-dependent density functional theory (TD-DFT) based electronic circular dichroism (ECD) calculation and chemical methods. All the isolates were evaluated for their inhibitory effects on cystathionine γ-lyase (CSE), a natural enzyme responsible for the synthesis of H2S. Compounds 4 and 5 represent rare examples of natural CSE inhibitors and the possible binding mode to CSE was further probed by molecular docking experiment.


Asunto(s)
Cistationina gamma-Liasa/antagonistas & inhibidores , Diterpenos/farmacología , Inhibidores Enzimáticos/farmacología , Glucósidos/farmacología , Tinospora/química , Cistationina gamma-Liasa/metabolismo , Teoría Funcional de la Densidad , Diterpenos/química , Diterpenos/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/aislamiento & purificación , Glucósidos/química , Glucósidos/aislamiento & purificación , Humanos , Estructura Molecular , Relación Estructura-Actividad
6.
Chembiochem ; 19(24): 2503-2521, 2018 12 18.
Artículo en Inglés | MEDLINE | ID: mdl-30152088

RESUMEN

Mucin-type O-glycosylation is the dominant form of glycosylation in eukaryotes and plays an important role in various physiological processes. The polypeptide GalNAc-transferase (GalNAc-T) catalyzes the first step in the attachment of mucin-type O-glycosylation. GalNAc-T was recently uncovered to be linked with cancer, atherogenic dyslipidemia, and X-linked hypophosphatemic rickets. Therefore, it has attracted increasing interest as a new target for exploring the underlying mechanism and developing new treatments for related diseases. Decades of studies on GalNAc-T have laid a stable foundation for understanding the catalytic mechanism, determining atom-resolution three-dimensional structures, and developing various types of biochemical assays as well as small-molecule inhibitor leads. Here, we systematically summarize this invaluable knowledge on GalNAc-T and cultivate new perspectives to foster breakthrough points for mucin-type O-glycosylation.


Asunto(s)
Inhibidores Enzimáticos/química , N-Acetilgalactosaminiltransferasas/antagonistas & inhibidores , N-Acetilgalactosaminiltransferasas/química , Secuencia de Aminoácidos , Catálisis , Dominio Catalítico , Pruebas de Enzimas/métodos , Inhibidores Enzimáticos/metabolismo , Glicosilación/efectos de los fármacos , Humanos , Mucinas/química , N-Acetilgalactosaminiltransferasas/análisis , N-Acetilgalactosaminiltransferasas/metabolismo , Unión Proteica , Polipéptido N-Acetilgalactosaminiltransferasa
7.
Am J Physiol Gastrointest Liver Physiol ; 308(6): G489-96, 2015 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-25591866

RESUMEN

Sensory transduction in esophageal afferents requires specific ion channels and receptors. TRPM8 is a new member of the transient receptor potential (TRP) channel family and participates in cold- and menthol-induced sensory transduction, but its role in visceral sensory transduction is still less clear. This study aims to determine TRPM8 function and expression in esophageal vagal afferent subtypes. TRPM8 agonist WS-12-induced responses were first determined in nodose and jugular neurons by calcium imaging and then investigated by whole cell patch-clamp recordings in Dil-labeled esophageal nodose and jugular neurons. Extracellular single-unit recordings were performed in nodose and jugular C fiber neurons using ex vivo esophageal-vagal preparations with intact nerve endings in the esophagus. TRPM8 mRNA expression was determined by single neuron RT-PCR in Dil-labeled esophageal nodose and jugular neurons. The TRPM8 agonist WS-12 elicited calcium influx in a subpopulation of jugular but not nodose neurons. WS-12 activated outwardly rectifying currents in esophageal Dil-labeled jugular but not nodose neurons in a dose-dependent manner, which could be inhibited by the TRPM8 inhibitor AMTB. WS-12 selectively evoked action potential discharges in esophageal jugular but not nodose C fibers. Consistently, TRPM8 transcripts were highly expressed in esophageal Dil-labeled TRPV1-positive jugular neurons. In summary, the present study demonstrated a preferential expression and function of TRPM8 in esophageal vagal jugular but not nodose neurons and C fiber subtypes. This provides a distinctive role of TRPM8 in esophageal sensory transduction and may lead to a better understanding of the mechanisms of esophageal sensation and nociception.


Asunto(s)
Esófago/inervación , Fibras Nerviosas Amielínicas/metabolismo , Ganglio Nudoso/metabolismo , Células Receptoras Sensoriales/metabolismo , Canales Catiónicos TRPM/metabolismo , Potenciales de Acción , Anilidas/farmacología , Animales , Benzamidas/farmacología , Señalización del Calcio , Relación Dosis-Respuesta a Droga , Cobayas , Masculino , Mentol/análogos & derivados , Mentol/farmacología , Fibras Nerviosas Amielínicas/efectos de los fármacos , Ganglio Nudoso/efectos de los fármacos , ARN Mensajero/metabolismo , Sensación , Células Receptoras Sensoriales/efectos de los fármacos , Canales Catiónicos TRPM/efectos de los fármacos , Canales Catiónicos TRPM/genética , Canales Catiónicos TRPV/metabolismo , Tiofenos/farmacología , Factores de Tiempo
8.
Am J Physiol Gastrointest Liver Physiol ; 308(6): G482-8, 2015 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-25591867

RESUMEN

Transient receptor potential A1 (TRPA1) is a newly defined cationic ion channel, which selectively expresses in primary sensory afferent nerve, and is essential in mediating inflammatory nociception. Our previous study demonstrated that TRPA1 plays an important role in tissue mast cell activation-induced increase in the excitability of esophageal vagal nodose C fibers. The present study aims to determine whether prolonged antigen exposure in vivo sensitizes TRPA1 in a guinea pig model of eosinophilic esophagitis (EoE). Antigen challenge-induced responses in esophageal mucosa were first assessed by histological stains and Ussing chamber studies. TRPA1 function in vagal sensory neurons was then studied by calcium imaging and by whole cell patch-clamp recordings in 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-labeled esophageal vagal nodose and jugular neurons. Extracellular single-unit recordings were performed in vagal nodose and jugular C-fiber neuron subtypes using ex vivo esophageal-vagal preparations with intact nerve endings in the esophagus. Antigen challenge significantly increased infiltrations of eosinophils and mast cells in the esophagus. TRPA1 agonist allyl isothiocyanate (AITC)-induced calcium influx in nodose and jugular neurons was significantly increased, and current densities in esophageal DiI-labeled nodose and jugular neurons were also significantly increased in antigen-challenged animals. Prolonged antigen challenge decreased esophageal epithelial barrier resistance, which allowed intraesophageal-infused AITC-activating nodose and jugular C fibers at their nerve endings. Collectively, these results demonstrated that prolonged antigen challenge sensitized TRPA1 in esophageal sensory neurons and afferent C fibers. This novel finding will help us to better understand the molecular mechanism underlying esophageal sensory and motor dysfunctions in EoE.


Asunto(s)
Alérgenos , Esofagitis Eosinofílica/metabolismo , Esófago/inervación , Fibras Nerviosas Amielínicas/metabolismo , Ovalbúmina , Células Receptoras Sensoriales/metabolismo , Canales de Potencial de Receptor Transitorio/metabolismo , Nervio Vago/metabolismo , Potenciales de Acción , Animales , Señalización del Calcio , Modelos Animales de Enfermedad , Esofagitis Eosinofílica/inmunología , Esofagitis Eosinofílica/fisiopatología , Eosinófilos/inmunología , Eosinófilos/metabolismo , Cobayas , Isotiocianatos/farmacología , Masculino , Mastocitos/inmunología , Mastocitos/metabolismo , Fibras Nerviosas Amielínicas/efectos de los fármacos , Fibras Nerviosas Amielínicas/inmunología , Ganglio Nudoso/efectos de los fármacos , Ganglio Nudoso/inmunología , Ganglio Nudoso/metabolismo , Sensación , Células Receptoras Sensoriales/efectos de los fármacos , Células Receptoras Sensoriales/inmunología , Factores de Tiempo , Canales de Potencial de Receptor Transitorio/agonistas , Canales de Potencial de Receptor Transitorio/inmunología , Nervio Vago/efectos de los fármacos , Nervio Vago/inmunología , Nervio Vago/fisiopatología
9.
J Biol Chem ; 288(18): 12544-53, 2013 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-23511633

RESUMEN

Potassium channel functions are often deciphered by using selective and potent scorpion toxins. Among these toxins, only a limited subset is capable of selectively blocking small conductance Ca(2+)-activated K(+) (SK) channels. The structural bases of this selective SK channel recognition remain unclear. In this work, we demonstrate the key role of the electric charges of two conserved arginine residues (Arg-485 and Arg-489) from the SK3 channel outer vestibule in the selective recognition by the SK3-blocking BmP05 toxin. Indeed, individually substituting these residues with histidyl or lysyl (maintaining the positive electric charge partially or fully), although decreasing BmP05 affinity, still preserved the toxin sensitivity profile of the SK3 channel (as evidenced by the lack of recognition by many other types of potassium channel-sensitive charybdotoxin). In contrast, when Arg-485 or Arg-489 of the SK3 channel was mutated to an acidic (Glu) or alcoholic (Ser) amino acid residue, the channel lost its sensitivity to BmP05 and became susceptible to the "new" blocking activity by charybdotoxin. In addition to these SK3 channel basic residues important for sensitivity, two acidic residues, Asp-492 and Asp-518, also located in the SK3 channel outer vestibule, were identified as being critical for toxin affinity. Furthermore, molecular modeling data indicate the existence of a compact SK3 channel turret conformation (like a peptide screener), where the basic rings of Arg-485 and Arg-489 are stabilized by strong ionic interactions with Asp-492 and Asp-518. In conclusion, the unique properties of Arg-485 and Arg-489 (spatial orientations and molecular interactions) in the SK3 channel account for its toxin sensitivity profile.


Asunto(s)
Arginina/metabolismo , Modelos Moleculares , Venenos de Escorpión/química , Canales de Potasio de Pequeña Conductancia Activados por el Calcio/antagonistas & inhibidores , Canales de Potasio de Pequeña Conductancia Activados por el Calcio/metabolismo , Arginina/genética , Caribdotoxina/química , Caribdotoxina/metabolismo , Células HEK293 , Humanos , Venenos de Escorpión/metabolismo , Canales de Potasio de Pequeña Conductancia Activados por el Calcio/química , Canales de Potasio de Pequeña Conductancia Activados por el Calcio/genética
10.
Am J Physiol Gastrointest Liver Physiol ; 307(4): G471-8, 2014 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-24994852

RESUMEN

Acid reflux-induced heartburn and noncardiac chest pain are processed peripherally by sensory nerve endings in the wall of the esophagus, but the underlying mechanism is still unclear. This study aims to determine the effects of acid on esophageal vagal nociceptive afferent subtypes. Extracellular single-unit recordings were performed in guinea pig vagal nodose or jugular C fiber neurons by using ex vivo esophageal-vagal preparations with intact nerve endings in the esophagus. We recorded action potentials (AP) of esophageal nodose or jugular C fibers evoked by acid perfusion and compared esophageal distension-evoked AP before and after acid perfusion. Acid perfusion for 30 min (pH range 7.4 to 5.8) did not evoke AP in nodose C fibers but significantly decreased their responses to esophageal distension, which could be recovered after washing out acid for 90 min. In jugular C fibers, acid perfusion not only evoked AP but also inhibited their responses to esophageal distension, which were not recovered after washing out acid for 120 min. Lower concentration of capsaicin perfusion mimicked acid-induced effects in nodose and jugular C fibers. Pretreatment with TRPV1 antagonist AMG9810, but not acid-sensing ion channel (ASIC) inhibitor amiloride, significantly inhibited acid-induced effects in nodose and jugular C fiber. These results demonstrate that esophageal vagal nociceptive afferent nerve subtypes display distinctive responses to acid. Acid activates jugular, but not nodose, C fibers and inhibits both of their responses to esophageal distension. These effects are mediated mainly through TRPV1. This inhibitory effect is a novel finding and may contribute to esophageal sensory/motor dysfunction in acid reflux diseases.


Asunto(s)
Ácidos/farmacología , Esófago/inervación , Fibras Nerviosas Amielínicas/efectos de los fármacos , Nocicepción/efectos de los fármacos , Ganglio Nudoso/efectos de los fármacos , Nervio Vago/efectos de los fármacos , Acrilamidas/farmacología , Potenciales de Acción/efectos de los fármacos , Amilorida/farmacología , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Capsaicina/farmacología , Cobayas , Pirosis/fisiopatología , Técnicas In Vitro , Masculino , Canales Catiónicos TRPV/efectos de los fármacos , Canales Catiónicos TRPV/fisiología
11.
Am J Physiol Gastrointest Liver Physiol ; 307(2): G149-57, 2014 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-24875100

RESUMEN

Eosinophilic esophagitis (EoE) is characterized with eosinophils and mast cells predominated allergic inflammation in the esophagus and present with esophageal dysfunctions such as dysphagia, food impaction, and heartburn. However, the underlying mechanism of esophageal dysfunctions is unclear. This study aims to determine whether neurons in the vagal sensory ganglia are modulated in a guinea pig model of EoE. Animals were actively sensitized by ovalbumin (OVA) and then challenged with aerosol OVA inhalation for 2 wk. This results in a mild esophagitis with increases in mast cells and eosinophils in the esophageal wall. Vagal nodose and jugular neurons were disassociated, and their responses to acid, capsaicin, and transient receptor potential vanilloid type 1 (TRPV1) antagonist AMG-9810 were studied by calcium imaging and whole cell patch-clamp recording. Compared with naïve animals, antigen challenge significantly increased acid responsiveness in both nodose and jugular neurons. Their responses to capsaicin were also increased after antigen challenge. AMG-9810, at a concentration that blocked capsaicin-evoked calcium influx, abolished the increase in acid-induced activation in both nodose and jugular neurons. Vagotomy strongly attenuated those increased responses of nodose and jugular neurons to both acid and capsaicin induced by antigen challenge. These data for the first time demonstrated that prolonged antigen challenge significantly increases acid responsiveness in vagal nodose and jugular ganglia neurons. This sensitization effect is mediated largely through TRPV1 and initiated at sensory nerve endings in the peripheral tissues. Allergen-induced enhancement of responsiveness to noxious stimulation by acid in sensory nerve may contribute to the development of esophageal dysfunctions such as heartburn in EoE.


Asunto(s)
Esofagitis Eosinofílica/metabolismo , Esófago/inervación , Pirosis/metabolismo , Ganglio Nudoso/metabolismo , Nervio Vago/metabolismo , Acrilamidas/farmacología , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Señalización del Calcio/efectos de los fármacos , Capsaicina/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Esofagitis Eosinofílica/inducido químicamente , Esofagitis Eosinofílica/fisiopatología , Cobayas , Pirosis/inducido químicamente , Pirosis/fisiopatología , Concentración de Iones de Hidrógeno , Masculino , Potenciales de la Membrana , Ganglio Nudoso/efectos de los fármacos , Ganglio Nudoso/fisiopatología , Ganglio Nudoso/cirugía , Ovalbúmina , Canales Catiónicos TRPV/efectos de los fármacos , Canales Catiónicos TRPV/metabolismo , Factores de Tiempo , Vagotomía , Nervio Vago/efectos de los fármacos , Nervio Vago/fisiopatología , Nervio Vago/cirugía
12.
Biochem Biophys Res Commun ; 447(1): 70-6, 2014 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-24704423

RESUMEN

Besides classical scorpion toxin-potassium channel binding modes, novel modes remain unknown. Here, we report a novel binding mode of native toxin BmKTX towards Kv1.3 channel. The combined experimental and computational data indicated that BmKTX-D33H analog used the classical anti-parallel ß-sheet domain as the channel-interacting interface together with the conserved channel pore-blocking Lys(26). However, the wild-type BmKTX was found to use Arg(23) rather than Lys(26) as the new pore-blocking residue, and mainly adopt the turn motif between the α-helix and antiparallel ß-sheet domains to recognize Kv1.3 channel. Together, these findings not only reveal that scorpion toxin-potassium channel interaction modes are more diverse than thought, but also highlight the functional role of toxin acidic residues in mediating diverse toxin-potassium channel binding modes.


Asunto(s)
Canal de Potasio Kv1.3/metabolismo , Venenos de Escorpión/metabolismo , Secuencia de Aminoácidos , Simulación por Computador , Células HEK293 , Humanos , Modelos Moleculares , Bloqueadores de los Canales de Potasio/química , Bloqueadores de los Canales de Potasio/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Venenos de Escorpión/genética
13.
J Biol Chem ; 287(17): 13813-21, 2012 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-22354971

RESUMEN

The potassium channel Kv1.3 is an attractive pharmacological target for autoimmune diseases. Specific peptide inhibitors are key prospects for diagnosing and treating these diseases. Here, we identified the first scorpion Kunitz-type potassium channel toxin family with three groups and seven members. In addition to their function as trypsin inhibitors with dissociation constants of 140 nM for recombinant LmKTT-1a, 160 nM for LmKTT-1b, 124 nM for LmKTT-1c, 136 nM for BmKTT-1, 420 nM for BmKTT-2, 760 nM for BmKTT-3, and 107 nM for Hg1, all seven recombinant scorpion Kunitz-type toxins could block the Kv1.3 channel. Electrophysiological experiments showed that six of seven scorpion toxins inhibited ~50-80% of Kv1.3 channel currents at a concentration of 1 µM. The exception was rBmKTT-3, which had weak activity. The IC(50) values of rBmKTT-1, rBmKTT-2, and rHg1 for Kv1.3 channels were ~129.7, 371.3, and 6.2 nM, respectively. Further pharmacological experiments indicated that rHg1 was a highly selective Kv1.3 channel inhibitor with weak affinity for other potassium channels. Different from classical Kunitz-type potassium channel toxins with N-terminal regions as the channel-interacting interfaces, the channel-interacting interface of Hg1 was in the C-terminal region. In conclusion, these findings describe the first scorpion Kunitz-type potassium channel toxin family, of which a novel inhibitor, Hg1, is specific for Kv1.3 channels. Their structural and functional diversity strongly suggest that Kunitz-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv1.3-mediated autoimmune diseases.


Asunto(s)
Péptidos/química , Canales de Potasio/química , Venenos de Escorpión/farmacología , Secuencia de Aminoácidos , Animales , Enfermedades Autoinmunes/metabolismo , Bovinos , Electrofisiología/métodos , Biblioteca de Genes , Células HEK293 , Humanos , Concentración 50 Inhibidora , Canal de Potasio Kv1.3/química , Datos de Secuencia Molecular , Mapeo de Interacción de Proteínas/métodos , Venenos de Escorpión/química , Escorpiones , Homología de Secuencia de Aminoácido , Porcinos , Inhibidores de Tripsina/farmacología , Ponzoñas/metabolismo
14.
J Biochem Mol Toxicol ; 25(4): 244-51, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21308893

RESUMEN

Toxins from the venoms of scorpion, snake, and spider are valuable tools to probe the structure-function relationship of ion channels. In this investigation, a new toxin gene encoding the peptide ImKTx1 was isolated from the venom gland of the scorpion Isometrus maculates by constructing cDNA library method, and the recombinant ImKTx1 peptide was characterized physiologically. The mature peptide of ImKTx1 has 39 amino acid residues including six cross-linked cysteines. The electrophysiological experiments showed that the recombinant ImKTx1 peptide had a pharmacological profile where it inhibited Kv1.3 channel currents with IC(50) of 1.70 n± 1.35 µM, whereas 10 µM rImKTx1 peptide inhibited about 40% Kv1.1 and 42% Kv1.2 channel currents, respectively. In addition, 10 µM rImKTx1 had no effect on the Nav1.2 and Nav1.4 channel currents. Multiple sequence alignments showed that ImKTx1 had no homologous toxin peptide, but it was similar with Ca(2+) channel toxins from scorpion and spider in the arrangement of cysteine residues. These results indicate that ImKTx1 is a new Kv1.3 channel blocker with a unique primary structure. Our results indicate the diversity of K(+) channel toxins from scorpion venoms and also provide a new molecular template targeting Kv1.3 channel.


Asunto(s)
Canal de Potasio Kv1.3/antagonistas & inhibidores , Péptidos/farmacología , Venenos de Escorpión/farmacología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , Células HEK293 , Humanos , Canal de Potasio Kv1.3/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Datos de Secuencia Molecular , Técnicas de Placa-Clamp , Péptidos/química , Péptidos/genética , Estructura Secundaria de Proteína , Venenos de Escorpión/química , Venenos de Escorpión/genética , Escorpiones/genética , Análisis de Secuencia de ADN
15.
Cell Chem Biol ; 27(12): 1483-1499.e9, 2020 12 17.
Artículo en Inglés | MEDLINE | ID: mdl-33186540

RESUMEN

H2S-producing enzymes in bacteria have been shown to be closely engaged in the process of microbial survival and antibiotic resistance. However, no inhibitors have been discovered for these enzymes, e.g., 3-mercaptopyruvate sulfurtransferase (MST). In the present study, we identified several classes of inhibitors for Escherichia coli MST (eMST) through high-throughput screening of ∼26,000 compounds. The thiazolidinedione-type inhibitors were found to selectively bind to Arg178 and Ser239 residues of eMST but hardly affected human MST. Moreover, the pioglitazone of this class concentration dependently accumulates the 3-mercaptopyruvate substrate and suppresses the H2S and reactive sulfane sulfur products in bacteria. Importantly, pioglitazone could potentiate the level of reactive oxygen species in cellulo and consequently enhance the antimicrobial effects of gentamicin and macrophages in culture. This study has identified the bioactive inhibitor of eMST, paving the way for the pharmacological targeting of eMST to synergistically control the survival of E. coli.


Asunto(s)
Diseño de Fármacos , Inhibidores Enzimáticos/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/enzimología , Sulfurtransferasas/antagonistas & inhibidores , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Escherichia coli/fisiología , Ensayos Analíticos de Alto Rendimiento , Humanos
16.
Neurogastroenterol Motil ; 31(4): e13543, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30663188

RESUMEN

INTRODUCTION: Acid reflux in the esophagus can induce painful sensations such as heartburn and non-cardiac chest pain. These nociceptive symptoms are initiated by activation of TRPV1-positive afferent C fibers in the esophagus. The present study aimed to explore a novel C fiber inhibition approach. We hypothesized that activation of TRPV1 by acid enabled QX-314, a membrane impermeable sodium channel blocker, to inhibit acid-induced activation of esophageal nociceptive C fiber neurons. METHOD: We determined the inhibitory effect of QX-314 in the presence of acid in guinea pig esophageal nociceptive vagal jugular C fiber neurons by both patch clamp recording in neuron soma and by extra-cellular recording at nerve terminals. KEY RESULTS: Our data demonstrated QX-314 alone did not inhibit sodium currents. However, when applied along with capsaicin to activate TRPV1, QX-314 was able to block sodium currents in esophageal-specific jugular C fiber neurons. We then showed that in the presence of acid, QX-314 significantly blocked acid-evoked activation of jugular C fiber neurons. This effect was attenuated by TRPV1 antagonist AMG9810, suggesting acid-mediated inhibitory effect of QX-314 was TRPV1-dependent. Finally, we provided evidence at nerve endings that acid-evoked action potential discharges in esophageal jugular C fibers were inhibited by QX-314 when applied in the presence of acid. CONCLUSION AND INFERENCES: Our data demonstrated that activation of TRPV1 by acid enabled membrane impermeable sodium channel blocker QX-314 to inhibit acid-induced activation in esophageal nociceptive C fibers. This supports a localized application of QX-314 in the esophagus to block esophageal nociception in acid reflux disorders.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Esófago/inervación , Lidocaína/análogos & derivados , Fibras Nerviosas Amielínicas/efectos de los fármacos , Nocicepción/efectos de los fármacos , Acrilamidas/farmacología , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Capsaicina/farmacología , Esófago/efectos de los fármacos , Cobayas , Ácido Clorhídrico/farmacología , Lidocaína/farmacología , Técnicas de Placa-Clamp , Canales Catiónicos TRPV/antagonistas & inhibidores
17.
Org Lett ; 21(10): 3678-3681, 2019 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-31038317

RESUMEN

Horisfieldones A (1) and B (2), two dimeric diarylpropanes featuring an unprecedentedly aromatic ring-contracted framework, were isolated from Horsfieldia kingii. Their structures and absolute configurations were determined by the inspection of extensive spectroscopic data and electronic circular dichroism calculations. Molecular modeling analysis, in vitro enzyme-based bioassays, and structure-activity relationship analysis of these isolates revealed that (+)-1 (IC50 = 35.1 ± 3.9 µM, SI > 11.4) could present a new class of human DOPA decarboxylase inhibitor.


Asunto(s)
Dopa-Decarboxilasa/farmacología , Propano/farmacología , Dicroismo Circular , Dopa-Decarboxilasa/química , Humanos , Concentración 50 Inhibidora , Modelos Moleculares , Estructura Molecular , Propano/análogos & derivados , Propano/química , Relación Estructura-Actividad
18.
J Med Chem ; 62(3): 1677-1683, 2019 02 14.
Artículo en Inglés | MEDLINE | ID: mdl-30562026

RESUMEN

We identify three submicromolar inhibitors with new chemical scaffolds for cystathionine γ-lyase (CSE) by a tandem-well-based high-throughput assay. NSC4056, the most potent inhibitor with an IC50 of 0.6 µM, which is also known as aurintricarboxylic acid, selectively binds to Arg and Tyr residues of CSE active site and preferably inhibits the CSE activity in cells rather than cystathionine ß-synthase (CBS), the other H2S-generating enzyme. Moreover, NSC4056 effectively rescues hypotension in hemorrhagic shock rats.


Asunto(s)
Ácido Aurintricarboxílico/farmacología , Cistationina gamma-Liasa/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Animales , Ácido Aurintricarboxílico/química , Ácido Aurintricarboxílico/metabolismo , Dominio Catalítico/efectos de los fármacos , Cistationina gamma-Liasa/química , Cistationina gamma-Liasa/metabolismo , Descubrimiento de Drogas , Inhibidores Enzimáticos/metabolismo , Células HEK293 , Humanos , Masculino , Ratones , Simulación del Acoplamiento Molecular , Estructura Molecular , Nitroquinolinas/farmacología , Unión Proteica , Células RAW 264.7 , Ratas Sprague-Dawley , Relación Estructura-Actividad
19.
Cell Death Dis ; 9(10): 1005, 2018 09 26.
Artículo en Inglés | MEDLINE | ID: mdl-30258181

RESUMEN

Cystathionine ß-synthase (CBS) is responsible for the first enzymatic reaction in the transsulfuration pathway of sulfur amino acids. The molecular function and mechanism of CBS as well as that of transsulfuration pathway remain ill-defined in cell proliferation and death. In the present study, we designed, synthesized and obtained a bioactive inhibitor CH004 for human CBS, which functions in vitro and in vivo. CH004 inhibits CBS activity, elevated the cellular homocysteine and suppressed the production of hydrogen sulfide in a dose-dependent manner in cells or in vivo. Chemical or genetic inhibition of CBS demonstrates that endogenous CBS is closely coupled with cell proliferation and cell cycle. Moreover, CH004 substantially retarded in vivo tumor growth in a xenograft mice model of liver cancer. Importantly, inhibition of CBS triggers ferroptosis in hepatocellular carcinoma. Overall, the study provides several clues for studying the interplays amongst transsulfuration pathway, ferroptosis and liver cancer.


Asunto(s)
Antineoplásicos/farmacología , Cistationina betasintasa/metabolismo , Animales , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/metabolismo , Ciclo Celular/efectos de los fármacos , Línea Celular , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Femenino , Células HCT116 , Células HEK293 , Células Hep G2 , Homocisteína/metabolismo , Humanos , Sulfuro de Hidrógeno/metabolismo , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/metabolismo , Ratones , Ratones Endogámicos ICR , Ratas
20.
Toxins (Basel) ; 8(4): 115, 2016 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-27104568

RESUMEN

The Kv1.3 channel-acting scorpion toxins usually adopt the conserved anti-parallel ß-sheet domain as the binding interface, but it remains challenging to discover some highly selective Kv1.3 channel-acting toxins. In this work, we investigated the pharmacological profile of the Kv1.3 channel-acting BmKTX-D33H, a structural analogue of the BmKTX scorpion toxin. Interestingly, BmKTX-D33H, with its conserved anti-parallel ß-sheet domain as a Kv1.3 channel-interacting interface, exhibited more than 1000-fold selectivity towards the Kv1.3 channel as compared to other K⁺ channels (including Kv1.1, Kv1.2, Kv1.7, Kv11.1, KCa2.2, KCa2.3, and KCa3.1). As expected, BmKTX-D33H was found to inhibit the cytokine production and proliferation of both Jurkat cells and human T cells in vitro. It also significantly improved the delayed-type hypersensitivity (DTH) responses, an autoreactive T cell-mediated inflammation in rats. Amino acid sequence alignment and structural analysis strongly suggest that the "evolutionary" Gly11 residue of BmKTX-D33H interacts with the turret domain of Kv1 channels; it appears to be a pivotal amino acid residue with regard to the selectivity of BmKTX-D33H towards the Kv1.3 channel (in comparison with the highly homologous scorpion toxins). Together, our data indicate that BmKTX-D33H is a Kv1.3 channel-specific blocker. Finally, the remarkable selectivity of BmKTX-D33H highlights the great potential of evolutionary-guided peptide drug design in future studies.


Asunto(s)
Factores Inmunológicos/farmacología , Canal de Potasio Kv1.3/fisiología , Bloqueadores de los Canales de Potasio/farmacología , Venenos de Escorpión/farmacología , Secuencia de Aminoácidos , Animales , Enfermedades Autoinmunes , Complejo CD3 , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Citocinas/metabolismo , Femenino , Células HEK293 , Humanos , Hipersensibilidad Tardía/inducido químicamente , Hipersensibilidad Tardía/tratamiento farmacológico , Factores Inmunológicos/química , Factores Inmunológicos/uso terapéutico , Células Jurkat , Ovalbúmina , Bloqueadores de los Canales de Potasio/química , Bloqueadores de los Canales de Potasio/uso terapéutico , Ratas Endogámicas Lew , Venenos de Escorpión/química , Venenos de Escorpión/uso terapéutico , Escorpiones , Alineación de Secuencia , Linfocitos T/efectos de los fármacos , Linfocitos T/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA